My Bots Weblog

«Un membre du personnel soignant de l'IHU Méditerranée Infection à Marseille montre deux plaquettes de médicaments: une de Nivaquine, qui contient de la chloroquine, et une de Plaqueril, qui contient de l'hydroxychloroquine, le 26 février 2020 Un membre du personnel soignant de l'IHU Méditerranée Infection à Marseille montre deux plaquettes de médicaments: une de Nivaquine, qui contient de la chloroquine, et une de Plaqueril, qui contient de l'hydroxychloroquine, le 26 février 2020 afp.com/GERARD JULIEN Cette étude sera pilotée par le CHU d'Anger. Les conditions de cette étude "ne laisseront pas de place au doute", assurent les médecins responsables de l'étude. C'est à Angers que l'on saura si l'hydroxychloroquine est efficace pour lutter contre le Covid-19. Le CHU de la ville va mener l'étude sur ce traitement très médiatisé ces derniers jours. C'est cet établissement qui a été choisi pour piloter l'étude car il dispose d'un stock d'hydroxychloroquine important pour des recherches qui sont déjà menées sur d'autres pathologies, rapporte France 3. Cette structure dispose également du placebo adéquat pour faire un comparatif en "double aveugle" sur les groupes de patients témoins.»...
Source: http://www.lexpress.fr | Source Status Categories: Crise/Analyse de Crise,Tendances

«A team of medical researchers and bioethicists at Oxford University has published results today in Science that furthers our understanding of coronavirus transmission. This evidence is enabling several international partners, including NHSX, a joint unit comprised of teams from NHS England and the UK's Department of Health & Social Care, and the Norwegian Institute of Public Health (FHI), to assess the feasibility of developing mobile apps for instant contact tracing in record time. If rapidly and widely developed, these mobile apps could help to significantly slow the rate of transmission, and support countries to emerge from lockdowns safely, as restrictions are gradually eased.»...
Source: http://medicalxpress.com | Source Status Categories: Crise/Analyse de Crise,Tendances

«COVID-19 Screening Tool This tool can help you understand what to do next about COVID-19. Let's all look out for each other by knowing our status, trying not to infect others, and reserving care for those in need.»...
Source: http://www.apple.com | Source Status Categories: Crise/Analyse de Crise,Tendances

«COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information from CDC: https://www.coronavirus.gov Get the latest research information from NIH:
Source: https://www.nih.gov | Source Status
Source: http://www.nih.gov | Source Status Categories: Crise/Analyse de Crise,Tendances

«Physicians at Johns Hopkins University are working to develop a safe way to use blood plasma from recovered coronavirus patients that could provide possible help or immunity to COVID-19 symptoms. The hope is the plasma transfusions could save lives as a vaccine is developed. The Baltimore-based research university is coordinating efforts with other medical centers from nearly two dozen hospitals and research centers, including the Mayo Clinic in Minnesota, the Stanford University Medical Center in California, and the Albert Einstein College of Medicine in New York.»...
Source: http://news3lv.com | Source Status Categories: Crise/Analyse de Crise,Tendances

«What's going on in the fifth largest economy in the world arguably points to a major collusion scandal in which the French government is helping Big Pharma to profit from the expansion of Covid-19. Informed French citizens are absolutely furious about it. My initial question to a serious, unimpeachable Paris source, jurist Valerie Bugault, was about the liaisons dangereuses between Macronism and Big Pharma and especially about the mysterious "disappearance" - more likely outright theft - of all the stocks of chloroquine in possession of the French government. Respected Professor Christian Perronne talked about the theft live in one of France's 24/7 info channels: "The central pharmacy for the hospitals announced today that they were facing a total rupture of stocks, that they were pillaged." With input from another, anonymous source, it's now possible to establish a timeline that puts in much-needed perspective the recent actions of the French government.»...
Source: http://asiatimes.com | Source Status Categories: Crise/Analyse de Crise,Tendances

«Abbott Laboratories said the US Food and Drug Administration (FDA) had given it emergency authorization to begin making the test available to healthcare providers as early as next week. The test, which is the size of a small toaster and uses molecular technology, also shows negative results within 13 minutes, the company said in a press statement. "The COVID-19 pandemic will be fought on multiple fronts, and a portable molecular test that offers results in minutes adds to the broad range of diagnostic solutions needed to combat this virus," said Abbott president and chief operating officer Robert Ford. The test's small size means it can be deployed outside the "traditional four walls of a hospital in outbreak hotspots," Ford said, and Abbott is working with the FDA to send it to virus epicenters.»...
Source: http://medicalxpress.com | Source Status Categories: Crise/Analyse de Crise,Tendances

«In a new study, researchers found that half of the patients they treated for mild COVID-19 infection still had coronavirus for up to eight days after symptoms disappeared. The research letter was published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine. In "Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection," Lixin Xie, MD, Lokesh Sharma, Ph.D., and co-authors report on a study of 16 patients with COVID-19, who were treated and released from the Treatment Center of PLA General Hospital in Beijing between January 28 and Feb. 9, 2020. Patients studied had a median age of 35.5 years. Researchers collected samples from throat swabs taken from all patients on alternate days and analyzed. Patients were discharged after their recovery and confirmation of negative viral status by at least two consecutive polymerase chain reaction (PCR) tests.» [...] «The authors had a special message for the medical community: "COVID-19 patients can be infectious even after their symptomatic recovery, so treat the asymptomatic/recently recovered patients as carefully as symptomatic patients." The researchers emphasized that all of these patients had milder infections and recovered from the disease, and that the study looked at a small number of patients. They noted that it is unclear whether similar results would hold true for more vulnerable patients such as the elderly, those with suppressed immune systems and patients on immunosuppressive therapies. "Further studies are needed to investigate if the real-time PCR-detected virus is capable of transmission in the later stages of COVID-19 infection," Dr. Xie added. »...
Source: http://medicalxpress.com | Source Status Categories: Crise/Analyse de Crise,Tendances

«C'est le nouveau plan de bataille des autorités sanitaires d'Ile-de-France, 12 millions d'habitants : armer en quelques jours mille lits de réanimation supplémentaires, c'est-à-dire pratiquement doubler la capacité actuelle, en « urgence absolue » afin d'affronter la déferlante de malades du coronavirus qui s'annonce dans les établissements de soins franciliens. En effet, avec 1 355 lits de réanimation occupés dans les établissements de soins jeudi 26 mars au soir, la capacité théorique régionale de 1 250 lits est maintenant largement dépassée. « Ce qui signifie 2 000 patients d'ici à la fin de semaine, il nous faut donc armer 1 000 lits de réanimation en plus sous 48 heures », révèle une note de l'Agence régionale de santé ÃŽle-de-France (ARS) adressée mercredi 25 mars à l'ensemble des établissements de soins de la région. Et d'avertir : « Si on prend 150 malades par jour, à la fin de la semaine le système est cuit ; et nous n'aurons aucune aide de personne. » Destinataires de ce document : l'ensemble des établissements franciliens, qu'ils soient publics, privés à but commercial ou parapublics.»...
Source: http://www.lepoint.fr | Source Status Categories: Crise/Analyse de Crise,Tendances

«Un décret pour encadrer l'usage de la chloroquine et clore la polémique sur la chloroquine. Le Directeur Général de la Santé a donné des détails sur la décision prise par le gouvernement quant à l'utilisation de la molécule. Il s'agit selon Jérôme Salomon « de faire bénéficier certains patients de cette piste thérapeutique » dans le cadre « d'un dispositif temporaire d'utilisation ».»...
Source: http://www.leparisien.fr | Source Status Categories: Crise/Analyse de Crise,Tendances

«Hydroxychloroquine, a medicine for malaria that President Donald Trump has touted as a treatment for coronavirus, was no more effective than conventional care, a small study found. The report published by the Journal of Zhejiang University in China showed that patients who got the medicine didn't fight off the new coronavirus more often than those who did not get the medicine. The study involved just 30 patients. Of the 15 patients given the malaria drug, 13 tested negative for the coronavirus after a week of treatment. Of the 15 patients who didn't get hydroxychloroquine, 14 tested negative for the virus. The results of the study weren't statistically significant. relates to Malaria Drug Chloroquine No Better Than Regular Coronavirus Care, Study Finds Hydroxychloroquine, particularly when given with the antibiotic azithromycin, has received widespread attention following a controversial, small study of about 40 patients hospitalized with Covid-19 in France. In that study, the drug appeared to help clear the virus from the bodies of 26 patients who were given the medication, based on samples taken from nasal swabs. Experts have criticized the design of the study, calling it interesting but far from definitive.» [...] «In the Chinese study, which was conducted by researchers from the department of infection and immunity at the Shanghai Public Health Clinical Center, the 15 patients who didn’t get hydroxychloroquine were treated with conventional care. This includes bed rest, oxgen inhalation, and the use of anti-viral drugs recommended in China’s treatment guidelines like lopinavir and ritonavir, and antibiotics when necessary. One patient treated with hydroxychloroquine progressed to severe disease during the study. Four patients given the medicine developed diarrhea and signs of potential liver damage, compared with three getting conventional treatment. The researchers concluded that additional studies using larger numbers of patients are needed to fully investigate the drug’s risks and benefits. »...
Source: http://www.bloomberg.com | Source Status Categories: Crise/Analyse de Crise,Tendances

«Vice President Mike Pence said Tuesday that "the FDA [Food and Drug Administration] is approving off-label use for the [anti-malarial drug] hydroxychloroquine right now" to help coronavirus patients. Pence made the comment during Fox News' virtual coronavirus town hall in response to a question from Dr. Mehmet Oz about the drug, which has shown encouraging signs in small, early tests. A similar drug, Chloroquine has also showed positive signs. Dr. Oz noted that "the FDA appropriately desires randomized critical trials for proof to guide the medical community," but asked the vice president how the clinical trials can be accelerated "while also satisfying the demand from physicians, front-line doctors, who want to use these pills for their patients and themselves?" In response, Pence said, "The good news is, the chloroquine medication, we actually deployed in the state of New York resources to be able to be administered to the people." New York has reported more than 25,600 confirmed coronavirus cases and 210 deaths, the most in the U.S., according to data compiled by Fox News.» [...] «“Doctors can prescribe that medication, which as you know is a perfectly legal and approved malaria medication," Pence told Dr. Oz, "but doctors can now prescribe chloroquine for that off-label purpose of dealing with the symptoms of coronavirus. We are making that clear across the country." VP Pence details what Trump is doing to support small businesses right nowVideo Preliminary studies sparked intense interest after President Trump tweeted that hydroxychloroquine plus an antibiotic could be “one of the biggest game changers in the history of medicine” and should “be put in use immediately.” The president cited a French study that gave the combination to six patients. Pence says 2,000 ventilators have been sent to New York »...
Source: http://www.foxnews.com | Source Status Categories: Crise/Analyse de Crise,Tendances

«An Arizona man is dead and his wife was hospitalized after the couple ingested a fish-tank solvent with chloroquine phosphate, the same active ingredient found in anti-malarial drugs that President Donald Trump has hailed as a possible treatment for the novel coronavirus. The woman told NBC News that the couple thought the drug compound Trump mentioned in a televised press conference was the same as the fish-tank cleaner they had in their home pantry. The two are not the same. Chloroquine, also known as chloroquine phosphate, is used in anti-malarial drugs available in the U.S. by prescription only, according to the Centers for Disease Control and Prevention. A variant, hydroxychloroquine, is an arthritis medicine that can also prevent malaria. The husband and wife were not alone in their confusion. A number of headlines describing the fatal mishap, including from mainstream news outlets, did not make it clear that the couple ingested fish-tank cleaner, rather than the drug form of chloroquine. One headline published before the Arizona couple's accident missed the distinction entirely. "Fish tank additive may treat coronavirus," said a March 20 headline from Valley News Live, a local news network serving TV stations in North Dakota.»...
Source: http://www.politifact.com | Source Status Categories: Crise/Analyse de Crise,Tendances

«The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA is facilitating access to convalescent plasma, antibody-rich blood products that are taken from blood donated by people who have recovered from the COVID-19 virus, that could shorten the length, or lessen the severity, of the illness. The agency will be using multiple pathways to support these efforts and has posted information for investigators wishing to study convalescent plasma for use in patients with serious or immediately life-threatening COVID-19 infections through the process of single patient emergency Investigational New Drug Applications for individual patients. The FDA also is actively engaging with researchers to discuss the possibility of collaboration on the development of a master protocol for the use of convalescent plasma, with the goal of reducing duplicative efforts.»...
Source: http://medicaldialogues.in | Source Status Categories: Crise/Analyse de Crise,Tendances

«Comme tous les sujets médiatiquement forts, le coronavirus SARS-CoV2 de 2019 n'échappe pas au sillon de la désinformation. Apparu dans la province chinoise du Hubei, l'épidémie provoquée par ce coronavirus - appelé désormais SARS-CoV2 et COVID-19 pour la maladie qu'il entraine chez le patient-continue d'alimenter les médias, mais aussi le web et les réseaux sociaux, parfois dans de mauvaises directions. L'Inserm vous propose de revenir sur les différentes formes que prend cette vague de désinformation afin de couper court aux fausses informations et mieux se repérer sur l'océan médiatique. S'agissant du SARS-CoV2 et du Covid-19 (la maladie contractée chez l'Homme, à distinguer du virus), la désinformation prend plusieurs formes. De la simple approximation dans les chiffres à la théorie du complot en passant par les révélations sans preuves, de nombreux supports relaient des « fake news ». Les sujets sensibles à la désinformation, eux aussi, varient : traitant tantôt de la nature du virus, tantôt de son vaccin.» [...] «Si la possibilité de pouvoir utiliser des traitements antipaludiques sûrs, déjà bien connus et peu coûteux chez les patients atteints de coronavirus est intéressante, il est primordial d’avoir une visibilité sur des données issus d’essais cliniques impliquant des patients infectés par SARS-Cov-2, publiées et donc rendues accessibles à la communauté scientifique internationale. Un essai clinique européen destiné à évaluer quatre traitements expérimentaux contre le COVID-19 a démarré le 22 mars 2020. Coordonné par l’Inserm dans le cadre du consortium REACTing, cet essai inclura au moins 800 patients français atteints de formes sévères du COVID-19 :
Source: https://presse.inserm.fr | Source Status A noter également qu’aucune prise de médicament quel qu’il soit n’est anodine. Les antipaludiques ne sont accessibles que sur prescription médicale. »...
Source: http://presse.inserm.fr | Source Status Categories: Crise/Analyse de Crise,Tendances

«Il se trouve déjà sur les tablettes des pharmacies de partout sur la planète, coute moins de 1 $ par jour et pourrait empêcher les complications graves de la COVID-19. Des chercheurs de l'Institut de cardiologie de Montréal démarrent une étude à grande échelle visant à tester un médicament appelé colchicine contre la détresse respiratoire causée par la COVID-19.»...
Source: http://www.lapresse.ca | Source Status Categories: Crise/Analyse de Crise,Tendances

«Bulletin épidémiologique hebdomadaire, 10 mars 2020, n°6-7 Prévalence des troubles du spectre de l'autisme Publié le 10 Mars 2020 Mis à jour le 10 mars 2020 Auteur : Ha Catherine, Chan Chee Christine Année de publication : 2020 Pages : 125-156 pdf Prévalence des troubles du spectre de l’autisme // Prevalence of Autism Spectrum Disorders Coordination scientifique // Scientific coordination Catherine Ha & Christine Chan Chee, Santé publique France, Saint-Maurice, France Et pour le Comité de rédaction du BEH : Florence Bodeau-Livinec, École des hautes études en santé publique, Rennes & Damien Mouly, Santé publique France – Occitanie, Toulouse, France
Source: https://www.santepubliquefrance.fr | Source Status
Source: http://www.santepubliquefrance.fr | Source Status Category:

«Bulletin épidémiologique hebdomadaire, 10 mars 2020, n°6-7 Prévalence des troubles du spectre de l'autisme Publié le 10 Mars 2020 Mis à jour le 10 mars 2020 Auteur : Ha Catherine, Chan Chee Christine Année de publication : 2020 Pages : 125-156 pdf Prévalence des troubles du spectre de l’autisme // Prevalence of Autism Spectrum Disorders Coordination scientifique // Scientific coordination Catherine Ha & Christine Chan Chee, Santé publique France, Saint-Maurice, France Et pour le Comité de rédaction du BEH : Florence Bodeau-Livinec, École des hautes études en santé publique, Rennes & Damien Mouly, Santé publique France – Occitanie, Toulouse, France
Source: https://www.santepubliquefrance.fr | Source Status
Source: http://www.santepubliquefrance.fr | Source Status Category:

«Nouvelle étape dans le cheminement à petits pas de la dématérialisation des procédures : le Portail du justiciable permet au justiciable, depuis le 21 février 2020, d'adresser des requêtes par voie électronique à certaines juridictions civiles. Cette fonction est une nouveauté, elle s'ajoute à : ...¢ la communication au justiciable : des informations relatives à l'état d'avancement des procédures civiles, des avis, convocations et récépissés émis par le greffe, ...¢ la consultation du dossier. Le portail ne se limite donc plus à des flux sortants de la juridiction à destination du justiciable, il accueille le flux entrant des actes de saisine, que sont les requêtes, soit le flux allant du justiciable vers la juridiction. On peut y voir un progrès pour le justiciable, qui peut être plus actif. Pour autant, les arrêtés techniques qui mettent en oeuvre cette avancée suscitent interrogations et étonnements de la part du processualiste. Au nombre de ces derniers, notons, sans développer davantage, que les arrêtés trouvent désormais leurs fondements, non seulement dans les dispositions du titre XXI du livre Ier du code de procédure civile, mais aussi dans des articles du code de procédure pénale (dont art. 801-1, 803-1, D. 589, etc.) : le portail s'ouvre en effet à cette procédure.»...
Source: http://www.dalloz-actualite.fr | Source Status Categories: Juridique,Tendances